Ampicillin and cefotaxime as a risk factor of neonatal death [9]

Pediatrics

Volumn 117, Issue 5, 2006, Pages 1857-

  Lee, Ping Ing ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; ANTIINFECTIVE AGENT; GENTAMICIN;

HEART ARREST; HUMAN; KIDNEY FAILURE; LETTER; LIVER DYSFUNCTION; MEDICAL RECORD; MENINGITIS; MULTIVARIATE ANALYSIS; NEWBORN; NEWBORN DEATH; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; UNIVARIATE ANALYSIS; BACTERIAL INFECTION; DRUG COMBINATION; INFANT MORTALITY; MORTALITY; NOTE;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CEFOTAXIME; DRUG THERAPY, COMBINATION; GENTAMICINS; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; RISK FACTORS;

EID: 33646840618     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-0067     Document Type: Letter

References (1)

1. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics. 2006;117:67-74